Exponent, Inc. (NASDAQ:EXPO – Get Free Report) Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $98.32, for a total value of $688,240.00. Following the completion of the sale, the director now owns 59,406 shares of the company’s stock, valued at $5,840,797.92. This trade represents a 10.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Exponent Price Performance
Shares of NASDAQ:EXPO traded down $0.62 during trading on Monday, hitting $96.78. 37,607 shares of the company were exchanged, compared to its average volume of 244,727. The stock has a market capitalization of $4.91 billion, a P/E ratio of 47.05 and a beta of 0.69. Exponent, Inc. has a 12-month low of $68.70 and a 12-month high of $115.75. The firm’s 50 day moving average price is $107.23 and its 200-day moving average price is $102.11.
Exponent Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a yield of 1.16%. Exponent’s payout ratio is currently 54.11%.
Institutional Investors Weigh In On Exponent
Analyst Ratings Changes
Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 price objective (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.
Read Our Latest Stock Report on EXPO
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- High Flyers: 3 Natural Gas Stocks for March 2022
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Find Undervalued Stocks
- Applied Materials Market Capitulates: Now is the Time to Buy
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.